NCT07162883 2025-09-09
Pharmacokinetic Study of QL2107 Versus Keytruda® for Adjuvant Therapy of Non-Small Cell Lung Cancer (NSCLC)
Qilu Pharmaceutical Co., Ltd.
Phase 3 Not yet recruiting
Qilu Pharmaceutical Co., Ltd.
Tempest Therapeutics
Changchun GeneScience Pharmaceutical Co., Ltd.
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.